Evidence map›Paper›PMID 31426368›Full record

ReviewVaccines2019

Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures-An Indian Perspective.

Raj Kumar Singh, Gaurav Kumar Sharma, Sonalika Mahajan, Kuldeep Dhama, Suresh H Basagoudanavar, Madhusudan Hosamani, B P Sreenivasa, Wanpen Chaicumpa, Vivek Kumar Gupta, Aniket Sanyal

Abstract readReview
In one paragraph

Review in Vaccines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Raj Kumar SinghICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243122, India.
Gaurav Kumar SharmaICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243122, India. gaurvet@gmail.com.ORCID 0000-0002-9996-9422
Sonalika MahajanICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243122, India.ORCID 0000-0001-7671-4251
Kuldeep DhamaICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243122, India.ORCID 0000-0001-7469-4752
Suresh H BasagoudanavarICAR-IVRI Bangalore Campus, Bangalore, Karnataka 560024, India.
Madhusudan HosamaniICAR-IVRI Bangalore Campus, Bangalore, Karnataka 560024, India.
B P SreenivasaICAR-IVRI Bangalore Campus, Bangalore, Karnataka 560024, India.
Wanpen ChaicumpaCenter of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Vivek Kumar GuptaICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243122, India.
Aniket SanyalICAR-IVRI Bangalore Campus, Bangalore, Karnataka 560024, India. aniket.sanyal@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A mass vaccination campaign in India seeks to control and eventually eradicate foot-and-mouth disease (FMD). Biosanitary measures along with FMD monitoring are being conducted along with vaccination. The implementation of the FMD control program has drastically reduced the incidence of FMD. However, cases are still reported, even in regions where vaccination is carried out regularly. Control of FMD outbreaks is difficult when the virus remains in circulation in the vaccinated population. Various FMD risk factors have been identified that are responsible for FMD in vaccinated areas. The factors are discussed along with strategies to address these challenges. The current chemically inactivated trivalent vaccine formulation containing strains of serotype O, A, and Asia 1 has limitations including thermolability and induction of only short-term immunity. Advantages and disadvantages of several new-generation alternate vaccine formulations are discussed. It is unfeasible to study every incidence of FMD in vaccinated animals/areas in such a big country as India with its huge livestock population. However, at the same time, it is absolutely necessary to identify the precise reason for vaccination failure. Failure to vaccinate is one reason for the occurrence of FMD in vaccinated areas. FMD epidemiology, emerging and re-emerging virus strains, and serological status over the past 10 years are discussed to understand the impact of vaccination and incidences of vaccination failure in India. Other factors that are important in vaccination failure that we discuss include disrupted herd immunity, health status of animals, FMD carrier status, and FMD prevalence in other species. Recommendations to boost the search of alternate vaccine formulation, strengthen the veterinary infrastructure, bolster the real-time monitoring of FMD, as well as a detailed investigation and documentation of every case of vaccination failure are provided with the goal of refining the control program.

Indexed as

foot-and-mouth diseaseimmunobiologyvaccination failurevaccinesvirus emergence

Identifiers

PMID31426368
PMCPMC6789522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.